S. Fox, MD, MPH Background-Pericardial and intrathoracic fat depots may represent novel risk factors for obesity-related cardiovascular disease. We sought to determine the prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat deposits. Methods and Results-Participants from the Framingham Heart Study (nϭ3312; mean age, 52 years; 48% women) underwent multidetector CT imaging in 2002 to 2005; high pericardial and high intrathoracic fat were defined on the basis of the sex-specific 90th percentile for these fat depots in a healthy reference sample. For men and women, the prevalence of high pericardial fat was 29.3% and 26.3%, respectively, and high intrathoracic fat was 31.4% and 35.3%, respectively. Overall, 22.1% of the sample was discordant for pericardial and intrathoracic fat depots: 8.3% had high pericardial but normal intrathoracic fat and 13.8% had high intrathoracic but normal pericardial fat. Higher body mass index, higher waist circumference, and increased prevalence of metabolic syndrome were more prevalent in participants with high intrathoracic fat depots than with high pericardial fat (PϽ0.05 for all comparisons). High abdominal visceral adipose tissue was more frequent in participants with high intrathoracic adipose tissue compared with those with high pericardial fat (PϽ0.001). Intrathoracic fat but not waist circumference was more highly correlated with visceral adipose tissue (rϭ0.76 and 0.78 in men and women, respectively; PϽ0.0001) than with subcutaneous adipose tissue (SAT) (rϭ0.46 and 0.54 in men and women, respectively; PϽ0.0001). Conclusions-Although prevalence of pericardial fat and intrathoracic fat were comparable at 30%, intrathoracic fat correlated more closely with metabolic risk and visceral fat. Intrathoracic fat may be a potential marker of metabolic risk and visceral fat on thoracic imaging. (Circ Cardiovasc Imaging. 2010;3:559-566.)
O besity, an important risk factor for cardiovascular disease, has been steadily rising in recent years. 1 Visceral adipose tissue deposits mediate a significant part of the risk of obesity-related vascular disease. 2, 3 Much of our understanding of the role of visceral adipose tissue has been derived from fat depots in the abdomen. However, emerging evidence suggests that thoracic visceral fat deposits, such as pericardial fat, may also have important cardiovascular effects that are locally mediated because of their proximity to cardiac structures. 4 -7 Pericardial fat deposits have been reported to be highly metabolically active and to secrete several vasoactive and inflammatory mediators. 8 Increased pericardial fat has also been associated with measures of increased adiposity, adverse cardiovascular risk factor profiles, and prevalent cardiovascular disease (CVD). 6, 7 Intrathoracic fat does not appear to have the same local cardiovascular effects as pericardial fat, possibly because of its lack of contiguity with cardiac structures. However, high levels of intrathoracic fat may represent a marker for increased visceral adipose tissue. As the result of the expanding cardiovascular indications for thoracic imaging, data on thoracic adipose tissue may be more readily available than abdominal visceral adipose tissue as a measure of cardiovascular and metabolic risk.
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Despite the importance of pericardial fat and other intrathoracic fat deposits as potential novel cardiovascular risk factors, the prevalence and age distribution of pericardial and intrathoracic fat have not been evaluated in a community-based sample. Furthermore, because of the highly correlated nature of pericardial, intrathoracic, and abdominal visceral fat, their respective contributions to metabolic risk have not been well established. We sought to estimate the prevalence and age distribution of these thoracic adipose deposits and to evaluate the metabolic risk factor profiles associated with different patterns of adipose tissue in the Framingham Offspring cohort, a middle-aged, community-based sample.
Methods

Study Sample
The study sample consisted of participants from the Framingham Heart Study Offspring and Third-Generation Cohorts who participated in the multidetector CT (MDCT) substudy between June 2002 and April 2005, as previously described. 2, 9, 10 Of the 3529 participants in the MDCT substudy, 3402 had interpretable values for both pericardial fat measures. An additional 55 participants were excluded for having previous CABG (which renders pericardial fat potentially uninterpretable), 21 participants were excluded for a distant study visit, and 14 participants were excluded because of missing covariates, resulting in a total of 3312 individuals for the present investigation.
The study protocol was approved by the institutional review boards of the Boston University Medical Center and Massachusetts General Hospital. All subjects provided written informed consent.
MDCT Scan Protocol
Participants underwent 8-slice MDCT (LightSpeed Ultra, General Electric, Milwaukee, Wis) in the supine position with an average of 48 contiguous 2.5-mm slices of the heart using a prospectively ECG-triggered CT scanning protocol, as previously described. 7 Participants also underwent a full thoracic scan after being briefly repositioned on the table. In addition, 25ϫ5-mm thick slices (120 kVp; 400 mA; gantry rotation time, 500 ms; table feed 3:1) were obtained spanning a 125-mm segment of the abdomen starting at the upper edge of S1.
Intrathoracic, Pericardial, and Abdominal Fat Volume Measurements
Using a dedicated offline workstation (Aquarius 3D Workstation, TeraRecon Inc, San Mateo, Calif), total thoracic and pericardial fat tissue volumes were measured. To determine the total thoracic and pericardial fat tissue volumes, a predefined image display setting based on Hounsfield units was used (window width, Ϫ195 to Ϫ45 Hounsfield units; window center, Ϫ120 Hounsfield units) that identified pixels that correspond with adipose tissue. Total thoracic and pericardial fat were quantified across the entire available imaging volume and were reported in cubic centimeters.
Using a semiautomatic segmentation technique, both total thoracic and pericardial fat volumes were determined as previously described ( Figure 1 ). 7, 11 Total thoracic fat volume was defined as total adipose tissue located within the lower two thirds of the thorax (ie, comprising the volume delimited by the level of the right pulmonary artery to the diaphragm and the chest wall to the descending aorta). Pericardial fat volume was defined as total adipose tissue measured within the pericardial sac. Intrathoracic fat was derived as the difference between total thoracic fat and pericardial fat. Segmentation of the overall volume was automatically interpolated using the manually defined tracings. When necessary, the reader made manual adjustments through the scan volumes to account for interpolating errors. On a random sample of 100 participants, intrareader and interreader reproducibility was excellent for total thoracic fat and pericardial fat, as previously reported. 7, 12 Visceral adipose tissue volumes were assessed, as previously described, 12 using the same image display windows as above (Aquarius 3D Workstation). Intrareader and interreader reproducibility was excellent for visceral abdominal fat, as previously reported. 7, 12 
Risk Factor Assessment
Risk factors and covariates were measured at the 7th examination (1998 to 2001) and at the first examination (2002 to 2005) for members of the Framingham Offspring and Third Generation Cohorts, respectively. Hypertension was defined as a systolic blood pressure Ն140 mm Hg, diastolic blood pressure Ն90 mm Hg, or treatment with an antihypertensive agent. Total and high-density lipoprotein (HDL) cholesterol, serum triglycerides, and fasting plasma glucose were measured on fasting morning samples. Elevated triglycerides were defined as Ն150 mg/dL or treatment with a lipid-lowering agent. Low HDL was defined as Ͻ40 mg/dL (men) and Ͻ50 mg/dL (women). Diabetes mellitus was defined as fasting plasma glucose Ն126 mg/dL or treatment with a hypoglycemic agent and/or insulin; impaired fasting glucose was defined as fasting plasma glucose from 100 to 125 mg/dL in the absence of treatment for diabetes mellitus. Metabolic syndrome (MetS) was defined on the basis of the Modified National Cholesterol Education Program Adult Treatment Panel III criteria. 13 Body mass index (BMI) was defined as weight (in kilograms) divided by the square of height (in meters), and waist circumference (WC) was measured at the level of the umbilicus. Prevalent CVD included any prior coronary heart disease (including myocardial infarction, angina pectoris, or coronary insufficiency), stroke (thromboembolic or hemorrhagic infarction or transient ischemic attack), intermittent claudication (defined as exertional calf discomfort relieved with rest), and congestive heart failure (according to the Framingham Heart Study CHF criteria 14 ). All CVD events were adjudicated by a panel of 3 Framingham investigators after review of all available medical records and Framingham Heart Study examination records including examining physician notes.
Statistical Analysis
Fat volumes were estimated for the 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles stratified by age and sex. To determine the prevalence of high pericardial and intrathoracic fat, a healthy referent sample was created by hierarchical exclusion of participants with the following covariates: BMI Ն30 kg/m 2 (nϭ901); presence of hypertension (or use of antihypertensive medications); triglycerides Ն150 mg/dL or lipid treatment; low HDL cholesterol (Ͻ40 mg/dL in men and Ͻ50 mg/dL in women); impaired fasting glucose; diabetes or use of hypoglycemic medications (nϭ1515); prevalent CVD (nϭ3); current tobacco smoking (nϭ117); and BMI Ͻ18.5 kg/m 2 (nϭ12), resulting in 285 men and 479 women in the healthy referent sample. We defined high pericardial and intrathoracic fat on the basis of fat volumes greater than the 90th percentile (sex-specific) from the healthy referent sample; participants with volumes equal or less than the 90th percentile were deemed to have "normal" volumes of pericardial or intrathoracic fat. The 90th percentile was chosen to ensure adequate sample size in the healthy referent sample to provide statistically robust estimates for the fat volume cutoff values. Prevalence estimates of high pericardial or high intrathoracic fat were stratified by sex and the following age categories: 35 to 44, 45 to 54, 55 to 64, 65 to 74, and 75 to 84 years.
To evaluate whether pericardial or intrathoracic fat was a better marker for indices of obesity and cardiometabolic risk factors, we examined sex-specific correlations between fat volumes and WC, visceral abdominal fat volume, and cardiometabolic risk factors. Furthermore, to establish the risk factor profiles associated with different patterns of thoracic adipose tissue, we stratified our sample into 4 mutually exclusive categories on the basis of pericardial and intrathoracic fat volumes: normal pericardial and intrathoracic fat, high pericardial fat/normal intrathoracic fat, normal pericardial fat/high intrathoracic fat, and high pericardial and intrathoracic fat. We used a stratified analysis by category of fat distribution to evaluate the association between prevalence of cardiometabolic risk factors and each fat deposit because of the high degree of collinearity between the different regional fat deposits that frequently lead to unstable estimates of association with standard linear regression models. Differences across the 4 categories and between the discordant categories (high pericardial/normal intrathoracic fat and normal pericardial/high intrathoracic fat categories) were assessed by sexspecific age-adjusted logistic regression using the Wald 2 contrast approach in SAS PROC LOGISTIC for dichotomous covariates and sex-specific, age-adjusted ANOVA using tests of effect for general contrasts in SAS PROG GLM for continuous covariates. We also evaluated the contributions of high pericardial and high intrathoracic fat in the context of visceral abdominal fat using the same methods. Similar analyses were conducted using generalized estimating equation logistic regression and analysis of variance (using SAS PROC GENMOD for each analytic method) to account for the correlation within family, assuming the within-family correlation followed the compound symmetry structure. Results from GEE models (not shown) were virtually the same as the results presented in the present study.
In secondary analyses, we further excluded all individuals from the healthy referent group who were overweight (BMI Ն25 kg/m 2 ) to create a lean healthy referent sample (nϭ134 men and 337 women) to provide the distribution of pericardial and intrathoracic fat volumes in healthy lean individuals. The thoracic fat volumes derived from this lean healthy reference sample may represent a better estimate of the normal physiological amounts of pericardial fat, but, because of the small sample used to derive these cutoffs, these estimates may be less statistically robust and subject to more random error. SAS version 9.1 was used to perform all computations; a 2-tailed probability value Ͻ0.05 was considered significant. No adjustment was made for multiple comparisons because of the exploratory nature of this study.
Results
There were a total of 3312 participants, including 1707 men and 1605 women, eligible for this analysis. The clinical characteristics of the overall sample are described in Table 1 .
Distribution of Pericardial and Intrathoracic Fat in the Community
The age-and sex-specific distribution for pericardial and intrathoracic fat volumes are presented in Table 2 . Both pericardial and intrathoracic fat volumes increased with age into the 7th decade for all percentiles of fat. For the overall sample, the median values for pericardial fat volumes in men and women were 117.5 cm 3 and 93.9 cm 3 , respectively, and for intrathoracic fat volumes they were 117.7 cm 3 and 58.4 cm 3 , respectively.
Prevalence of High Pericardial Fat and High Intrathoracic Fat
On the basis of the age-and sex-specific 90th percentile cutoff for pericardial fat and intrathoracic fat volumes, we defined a group of participants with high pericardial and intrathoracic fat, respectively. The prevalences of high pericardial and high intrathoracic fat stratified by age are reported in Table 3 . The overall prevalence for pericardial fat was 29.3% (men) and 26.3% (women), and for intrathoracic fat it was 31.4% (men) and 35.3% (women). A general trend of increasing prevalence of high pericardial and intrathoracic fat deposits was also noted with increasing age. For both men and women, the prevalence of high thoracic depots peaked in the 65-to 74-year age group, except for intrathoracic fat in women, which peaked in the 55-to 64-year age group. A trend toward decreased prevalence of high intrathoracic and pericardial deposits beyond the 7th decade was also observed.
In a secondary analysis, we created a lean, healthy reference sample by further excluding overweight subjects. Using the 90th percentile cutoffs derived from this reference sample, the overall prevalence for pericardial fat was 43.8% (men) and 30.3% (women), and for intrathoracic fat it was 48.9% (men) and 46.6% (women). Table 1A and 1B). Both intrathoracic fat and WC were similarly associated with visceral abdominal fat (rϭ0.76 and 0.72 for intrathoracic fat and WC, respectively, in men and rϭ0.72 and 0.72 for intrathoracic fat and waist circumference, respectively, in women). More importantly, we found that intrathoracic fat was more strongly correlated with visceral abdominal fat than with subcutaneous fat, whereas WC was highly correlated with both visceral abdominal and subcutaneous fat.
Correlations Between Fat Depots, WC, and Metabolic Risk Factors
Cardiovascular Risk Factor Profiles by Patterns of Intrathoracic and Pericardial Fat Distribution
To evaluate the unique contributions of each regional fat depot to prevalent cardiovascular risk profiles, we examined risk factors across different patterns of fat distribution and specifically across groups discordant for thoracic fat deposits ( Table 4 and Figure 1 ). In our sample, 23.1% of men and 20.9% of men were discordant for pericardial and intrathoracic fat depots: 10.6% of men and 5.9% of women had high pericardial but normal intrathoracic fat, and 12.5% of men and 15.0% of women had high intrathoracic but normal pericardial fat. In both men and women, we observed a trend toward a higher prevalence for all cardiovascular risk factors, including diabetes, low HDL, hypertension, and MetS across categories of high intrathoracic and pericardial fat deposits (PϽ0.001 for trend) (Figure 2 ). Prevalence of CVD also increased similarly in both sexes across categories of high intrathoracic and high pericardial fat (Pϭ0.04 and 0.02 for trend, in men and women, respectively). Measures of adiposity followed a similar trend with increased BMI, WC, and visceral abdominal fat volume across categories of high intrathoracic and high pericardial fat deposits (Table 4 ).
In discordant subjects, with high intrathoracic fat compared with those with high pericardial fat, the prevalence of MetS was significantly higher in men (PϽ0.05), whereas hypertension, low HDL, and MetS were significantly higher in women (PϽ0.05 for all) (Figure 2 ). There was no statistically significant difference in the prevalence of CVD across discordant categories of pericardial and intrathoracic fat. In both men and women, BMI, WC, MetS, and visceral adipose tissue volumes were significantly higher in individuals with high intrathoracic fat as compared with individuals with high pericardial fat (PϽ0.001 for all comparisons) ( Table 4 ).
Cardiovascular Risk Factor Profiles by Patterns of Intrathoracic, Pericardial, and Abdominal Fat Distribution
To further evaluate the contributions of intrathoracic fat deposits on cardiovascular risk factor profiles in the context of abdominal visceral fat, we evaluated the prevalence of risk factors across different patterns of intrathoracic and abdominal visceral fat distributions (Figure 3 ). We found evidence for a trend toward increasing prevalence of cardiac risk factors and MetS across categories of high intrathoracic fat and high visceral fat (PՅ0.001 for trend). When individuals discordant for high intrathoracic fat and high visceral abdominal fat were compared, a higher prevalence of high triglycerides, low HDL, and MetS was observed (PϽ0.001 for all) among individuals with high visceral fat compared with high intrathoracic fat. A higher BMI and increased WC were also identified for individuals with high visceral abdominal fat as compared with high intrathoracic fat (PϽ0.001 for both). Similar results were also observed in sex-specific comparisons, except that hypertension was found to be more frequent in women but not men with high visceral abdominal fat as compared with high intrathoracic fat. When individuals discordant for high pericardial fat and high visceral abdominal fat were compared, all risk factors and measures of adiposity were higher among individuals with high abdominal visceral fat compared with high pericardial fat (supplementary Table 2 ). None of the metabolic risk factors or measures of adiposity that we examined tracked more closely with a thoracic fat depot (intrathoracic or pericardial fat) as compared with visceral abdominal fat.
Discussion
In this community-based sample of more than 3000 middleaged individuals, nearly one third have high pericardial fat and high intrathoracic fat volumes. When we further excluded overweight individuals from the healthy referent sample, the prevalence of high pericardial fat and high intrathoracic fat was as high as Ϸ40% and Ϸ50%, respectively. By the 7th decade of life, nearly half of individuals in the community have increased pericardial and intrathoracic fat. We show that high intrathoracic fat deposits are cross-sectionally associated with increased prevalence of cardiometabolic risk factors. Participants with both high pericardial fat and high intratho-racic fat or those with both high intrathoracic fat and high visceral abdominal fat were both found to have a more adverse cardiometabolic profiles compared with individuals with Յ1 high regional fat deposit.
To evaluate the contribution of each thoracic deposit to cardiometabolic risk, we examined participants discordant for pericardial and intrathoracic fat deposits. Higher BMI and higher WC and prevalent MetS were more likely to track with high intrathoracic fat than with high pericardial fat. Ultimately, we show that these risk factors track more closely with visceral abdominal fat than with either thoracic fat deposit, which underscores the importance of the abdominal visceral fat compartment as a marker of cardiometabolic risk. However, because visceral abdominal fat is not frequently available during cardiac imaging, we evaluated whether thoracic fat depots could be used as a proxy for visceral abdominal fat. We found that intrathoracic fat was a better proxy for visceral abdominal fat than pericardial fat. More importantly, we also show that intrathoracic fat is better able to discriminate between visceral abdominal fat and subcutaneous abdominal fat, as compared with WC. This suggests that intrathoracic fat may be a useful marker of visceral abdominal fat on thoracic imaging.
In the Context of the Current Literature
We present a comprehensive age-and sex-specific description of the distribution of thoracic fat deposits in the community. Our estimates of prevalence of high pericardial and high intrathoracic fat are consistent with current estimates of obesity in the US population of 32.2% 1 and the prevalence of high volumes of other regional adipose deposits such as high subcutaneous fat (30%) and high visceral abdominal fat (30%), which we have reported previously. 15 High intrathoracic fat in the context of high visceral abdominal fat may also be a marker of increased obesity-related cardiometabolic risk, given the more adverse risk factor profile observed among participants with high levels of both abdominal and thoracic fat. Similar observations have also been reported for other regional fat deposits. 7, 15 Several studies have previously reported associations between pericardial fat, cardiometabolic risk factors, and measures of adiposity. 7,16 -18 Iacobellis et al 17 have reported that pericardial fat thickness, as measured by echocardiography, was associated with WC, diastolic blood pressure, and fasting insulin levels. We have shown that increased pericardial fat is associated with cardiovascular disease risk factors, prevalent CVD, and coronary calcium. 6, 7 We and others have also reported that pericardial fat is highly correlated with visceral abdominal fat. 7,16 -18 We now extend these findings by demonstrating similar associations with intrathoracic fat and cardiovascular risk factors. More importantly, we show that high intrathoracic fat is more closely associated with adverse cardiovascular risk factor profiles than high pericardial fat. Intrathoracic fat but not pericardial fat also tracked more closely with increased measures of central adiposity and prevalent MetS.
Our findings that intrathoracic fat more closely relates to cardiometabolic risk factors than pericardial fat may also explain why pericardial fat but not intrathoracic fat has been independently associated with prevalent CVD 6 and coronary artery calcium. 7 Our results indicate that the association between pericardial fat and CVD probably is not mediated by conventional cardiometabolic risk factors, whereas the weak association between intrathoracic fat and CVD may be mediated by these risk factors.
Potential Mechanisms
Visceral fat is emerging as a potentially important cardiovascular and metabolic risk factor. Given the highly collinear relationships between different fat deposits, the unique contributions of these thoracic fat deposits have previously remained largely unexplored. Because of the shared embryological origin between pericardial fat and visceral abdominal fat, it has been hypothesized that pericardial fat could act as the regional depot for visceral fat accumulation in the chest. 19 Our results suggest that intrathoracic fat may represent a better proxy for visceral fat accumulation in the thorax than pericardial fat.
Our findings that MetS tracked with high intrathoracic fat probably is due to the confounding effects of elevated levels of BMI, WC, and visceral adipose tissue observed among individuals with high intrathoracic fat and not due to any specific properties of intrathoracic fat. However, the association of increased measures of adiposity, visceral abdominal fat, and prevalent MetS with high intrathoracic fat suggests that measures of intrathoracic fat volumes could represent a potential marker for increased metabolic risk, particularly when volumetric data on visceral abdominal fat is unavailable.
Implications for Further Research
Given the expanding cardiovascular uses of thoracic CT imaging, intrathoracic and pericardial fat volumes will be increasingly available in both clinical and research settings and could be used as a marker for increased metabolic risk. In the present study, we have provided age-and sex-specific cut-points for volumes of thoracic fat deposits that are based on a healthy reference sample derived from a communitybased cohort that could be used as a nomogram for future studies evaluating pericardial and intrathoracic fat. It has been suggested that pericardial fat may be a modifiable risk factor because this fat deposit has been shown to decrease with exercise and diet. 20, 21 Our nomogram of thoracic fat volumes could be used to evaluate whether changes across percentiles lead to meaningful improvements in cardiovascular risk. Determining the specific fat volume cut-points associated with increased cardiometabolic risk longitudinally would significantly enhance our current nomogram and may be the subject of future research.
Strengths and Limitations
The major strengths of our study are the relatively large sample drawn from a community-based cohort, which limited referral bias and provided adequate power for a stratified analysis by regional fat distribution. We also used a highly reproducible CT volumetric assessment of fat deposits that represents the gold standard for fat quantification. Our study also had several limitations that deserve further comment. Our sample was derived from a primarily white community of European descent; therefore, our results may not be generalizable to other ethnicities. Furthermore, our observational study used prevalent data to provide cross-sectional associations and therefore we cannot infer causality.
Conclusion
We have shown that approximately one third of a community-based sample has high pericardial and high intrathoracic fat, potential novel cardiovascular and metabolic risk factors. Although visceral abdominal fat was most closely related to metabolic risk than any other fat depot, intrathoracic fat was more highly correlated with cardiometabolic risk factors than pericardial fat. Intrathoracic fat may represent a useful marker for increased metabolic risk and visceral fat on thoracic imaging.
